Predicting Short-Term Mortality in Severe Cirrhosis: An Interpretable Machine Learning Model Integrating Routine Clinical Indicators
Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
Background
The critical need for precise risk stratification in severe liver cirrhosis is underscored by its substantial 30-day mortality rates, demanding reliable tools to guide clinical interventions.
Objective
To establish a machine learning-driven prognostic model for short-term mortality prediction in decompensated cirrhosis through comprehensive analysis of critical care data.
Methods
This retrospective cohort study analyzed 1,044 carefully curated cases from the MIMIC-IV database, randomly divided into training (n=740) and validation (n=304) sets. We developed a machine learning model incorporating multidimensional clinical parameters, with rigorous evaluation and internal validation. Short-term survival was analyzed via bootstrap-validated Cox proportional hazards regression. Prognostic heterogeneity across INR-based strata was examined.
Results
The final prediction model incorporated eight significant predictors: age (OR 1.040, 95% CI 1.022-1.058), international normalized ratio (OR 1.496, 95%CI 1.297-1726), creatinine (OR 1.210, 95%CI 1.109-1.319), platelets (OR 0.995, 95%CI 0.993-0.997), leukocytes (OR 1.120, 95%CI 1.083-1.159), total bilirubin (OR 1.031, 95%CI 1.006-1.057), peptic ulcer (OR 0.297, 95%CI 0.120-0.734), and metastatic solid tumors (OR 3.001, 95%CI 1.211-7.436). The model demonstrated excellent discrimination with an AUC of 0.851 (95%CI: 0.800–0.901) in the validation cohort. Cox regression analysis confirmed these findings and identified additional associations with aspartate aminotransferase and red blood cell levels. Subgroup analysis revealed significant mortality variations across different INR ranges (P<0.001).
Conclusions
Our prediction model identifies high-risk cirrhotic patients and highlights critical prognostic factors, offering clinicians a valuable tool for risk stratification and timely intervention. The strong correlation between laboratory markers, complications, and outcomes underscores the importance of close monitoring in this population.
